These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6973859)

  • 21. Quantitative studies of the activation of cytotoxic lymphocyte precursor cells.
    Miller RG; Teh HS; Harley E; Phillips RA
    Immunol Rev; 1977; 35():38-58. PubMed ID: 330390
    [No Abstract]   [Full Text] [Related]  

  • 22. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell hybrids with T cell functions.
    Simpson E; Kontiainen S; Herzenberg LA; Bohrer E; Torano A; Vogt P; Beverley P; Fitzpatrick W; Feldmann M
    Curr Top Microbiol Immunol; 1978; 81():195-202. PubMed ID: 80303
    [No Abstract]   [Full Text] [Related]  

  • 24. Association of host immunity with 5-fluorouracil-initiated cure of plasmacytoma LPC-1 in BALB/c mice.
    Teller MN; Faanes RB
    Cancer Res; 1980 Aug; 40(8 Pt 1):2790-5. PubMed ID: 6966969
    [No Abstract]   [Full Text] [Related]  

  • 25. Ontogeny of anti-self-trinitrophenyl cytotoxic T-cell responses.
    Schmitt-Verhulst AM; Cooley MA; Buferne M
    Thymus; 1981 Aug; 3(2):77-85. PubMed ID: 6974916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines.
    Stadler BM; Dougherty SF; Farrar JJ; Oppenheim JJ
    J Immunol; 1981 Nov; 127(5):1936-40. PubMed ID: 6975304
    [No Abstract]   [Full Text] [Related]  

  • 27. T cell hybrids with specificity for individual antigens.
    Ruddle NH
    Curr Top Microbiol Immunol; 1978; 81():203-11. PubMed ID: 80304
    [No Abstract]   [Full Text] [Related]  

  • 28. [Activation of the membrane toxicity and cytotoxicity of the tumor cell by leukocyte and fibroblast interferon].
    Sterlina AG; Malinovskaia VV; Bogdashin IV; Fuks BB
    Biull Eksp Biol Med; 1982 Dec; 94(12):80-2. PubMed ID: 7150772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The beta-carotene stimulation of cellular immunity reactions in mice].
    Abronina IF; Ramanauskaĭte RIu; Andreĭchuk TN; Rytenko AN; Korostelev SA
    Biull Eksp Biol Med; 1993 Sep; 116(9):295-8. PubMed ID: 8118006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNF receptor involvement in TNF-mediated activities against syngeneic malignant and normal mouse thymocytes.
    Fishman M; Larche M
    Cell Immunol; 1993 Dec; 152(2):510-21. PubMed ID: 8258153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rat antisera directed against alloimmune murine cytotoxic T lymphocytes inhibit cytotoxic T-lymphocyte and natural killer activity: strain specificity of inhibition.
    Lawlor DA; Saunders PH; Ware CF
    Cell Immunol; 1982 Mar; 68(1):128-38. PubMed ID: 6979399
    [No Abstract]   [Full Text] [Related]  

  • 34. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1994 Dec; 153(11):4959-68. PubMed ID: 7963559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.
    Rohrer JW; Culpepper C; Barsoum AL; Coggin JH
    J Immunol; 1995 Mar; 154(5):2266-80. PubMed ID: 7868899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
    Wright SC; Bonavida B
    J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139
    [No Abstract]   [Full Text] [Related]  

  • 37. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
    Chou YK; Culbertson N; Rich C; LaTocha D; Buenafe AC; Huan J; Link J; Wands JM; Born WK; Offner H; Bourdette DN; Burrows GG; Vandenbark AA
    J Neurosci Res; 2004 Sep; 77(5):670-80. PubMed ID: 15352213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antitumor activity on murine mastocytoma induced by immunization with fusion of dendritic cells and P815 cells in mice].
    Wang QC; Feng ZH; Zhou YX; Nie QH; Bai XF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):559-60. PubMed ID: 15387915
    [No Abstract]   [Full Text] [Related]  

  • 39. Generation of anti-tumour effector T cells from naïve T cells by stimulation with dendritic/tumour fusion cells.
    Ishida A; Tanaka H; Hiura T; Miura S; Watanabe S; Matsuyama K; Kuriyama H; Tanaka J; Kagamu H; Gejyo F; Yoshizawa H
    Scand J Immunol; 2007 Nov; 66(5):546-54. PubMed ID: 17953530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressor cells in neoplastic disease.
    Broder S; Muul L; Waldmann TA
    J Natl Cancer Inst; 1978 Jul; 61(1):5-11. PubMed ID: 353295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.